Spyre Therapeutics Receivables Turnover (Quarterly) Analysis

Spyre Therapeutics, Inc. (SYRE)

43.53 +0.08 (+0.18%) USD | NASDAQ | Feb 25, 10:32

Receivables Turnover (Quarterly) Chart

View Receivables Turnover (Quarterly) for SYRE.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Receivables Turnover (Quarterly) Chart

Start Trial

Historical Data

View Historical Data

Start Trial

Receivables Turnover Ratio Definition

View Receivables Turnover Ratio Definition

Start Trial

The receivable turnover ratio quantifies a company's ability to collect liabilities/debts. It helps investors gauge the efficiency of a company's collection and credit policies.

Read full definition.

Receivables Turnover (Quarterly) Range, Past 5 Years

View Receivables Turnover (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Receivables Turnover (Quarterly) Benchmarks

View Receivables Turnover (Quarterly) Benchmarks

Start Trial

PTC Therapeutics, Inc.	Upgrade
Tandem Diabetes Care, Inc.	Upgrade
ACADIA Pharmaceuticals, Inc.	Upgrade
Alnylam Pharmaceuticals, Inc.	Upgrade
Savara, Inc.	--